Arch Pharmalabs buys Watsol Organics

Hyderabad, Aug 22 (UNI) Arch Pharmalabs Ltd today announced the acquisition of Watsol Organics ltd, a manufacturer of pharmaceuticals and agro-chemical intermediates in the city.

Watsol Organics was acquired for an enterprise value of Rs 30 crore. The acquisition would help Arch Pharmalabs to access key raw materials and intermediates in the manufacture of Isoxazole side chains, a release here today said.

This was the fifth acquisition by the company and the third in Hyderabad. The company would invest to the tune of Rs 120 crore for capacity expansion.

The acquisition would strategically supplement and further augment the global leadership position in the Isoxazole side chains business, thus meeting the growing demand in the industry, it added.

UNI